Director Bartholdson acquires 105,500 shares across 2 transactions ($8.55 avg) despite poor timing record
John A. Bartholdson, Director of Bioventus Inc., executed 2 separate purchases totaling 105,500 shares for $901,702.35 at $8.55 per share on August 16 and August 19, 2024. His prior trades at BVS show a concerning pattern: 3 prior buys across 2023 all yielded negative 30- and 90-day returns, with a 0% win rate at the 90-day mark. Cross-ticker, his 3 prior open-market buys averaged -32.2% over 30 days and -21.6% over 90 days with a 0.00% win rate. The company remains unprofitable with annual revenue growth of +0.0% and trailing net income of -$23,992,000.00. While the stock has rallied +14.4% over 30 days and +30.2% over 90 days from prior lows, the director's historical execution timing provides no statistical support for forward momentum.